The serum concentration of the receptor activator of nuclear factor-kB ligand (RANKL), osteoprotegerin (OPG) and lipids profile in children with nephrotic syndrome

被引：0
|
作者：
Panczyk-Tomaszewska, M. [1 ]
Ziolkowska, H. [1 ]
Adamczuk, D. [1 ]
Gorska, E. [2 ]
Stelmaszczyk-Emmel, A. [2 ]
Roszkowska-Blaim, M. [1 ]
机构：
[1] Med Univ Warsaw, Dept Pediat & Nephrol, Warsaw, Poland
[2] Med Univ Warsaw, Dept Lab Diagnost & Clin lmuunol Dev Age, Warsaw, Poland
来源：
BONE | 2009年 / 45卷
关键词：
D O I：
10.1016/j.bone.2009.04.121
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S86 / S86
页数：1
相关论文
共 50 条
  • [1] A correlation between receptor activator of nuclear factor-kb ligand (RANKL) and osteoprotegerin (OPG) with bone mineral density (BMD)
    Aulia, F. A.
    Lestari, S. U.
    Anniwati, L.
    Mudjanarko, S. W.
    Marpaung, F. R.
    CLINICA CHIMICA ACTA, 2022, 530 : S43 - S43
  • [2] Duchenne muscular dystrophy: RANK/RANKL/OPG (receptor activator of nuclear factor-kB/RANK ligand/osteoprotegerin) system and glucocorticoids
    Atilano-Miguel, Salvador
    Barbosa-Cortes, Lourdes
    Ortiz-Muniz, Rocio
    BOLETIN MEDICO DEL HOSPITAL INFANTIL DE MEXICO, 2022, 79 (05): : 275 - 283
  • [3] The Receptor Activator of Nuclear Factor-kB Ligand (RANKL)/Osteoprotegerin (OPG) axis is severely disrupted in patients with solid tumours and osseous metastasis
    Mountzios, G.
    Pavlakis, G.
    Bamias, A.
    Papadopoulos, G.
    Papasavas, P.
    Dimopoulos, M.
    Terpos, E.
    EJC SUPPLEMENTS, 2005, 3 (02): : 46 - 46
  • [4] Levels of osteoprotegerin (OPG) and receptor activator for nuclear factor kappa B ligand (RANKL) in serum: Are they of any help?Osteoprotegerin (OPG) und Receptor Activator for Nuclear Factor kappaB Ligand (RANKL) Bestimmung im Serum: Sinn oder Unsinn?
    Doris Wagner
    Astrid Fahrleitner-Pammer
    Wiener Medizinische Wochenschrift, 2010, 160 (17-18) : 452 - 457
  • [5] Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children
    Anna Wasilewska
    Agnieszka Rybi-Szuminska
    Walentyna Zoch-Zwierz
    Pediatric Nephrology, 2010, 25 : 2067 - 2075
  • [6] Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children
    Wasilewska, Anna
    Rybi-Szuminska, Agnieszka
    Zoch-Zwierz, Walentyna
    PEDIATRIC NEPHROLOGY, 2010, 25 (10) : 2067 - 2075
  • [7] Plasma and drainage fluid levels of soluble receptor activator of nuclear factor-kB (sRANK), soluble receptor activator of nuclear factor-kB ligand (sRANKL) and osteoprotegerin (OPG) during proximal humerus fracture healing
    Colombini, Alessandra
    Lombardi, Giovanni
    Galliera, Emanuela
    Dogliotti, Giada
    Randelli, Pietro
    Meerssemann, Alexander
    Mineo, Giuseppe
    Cabitza, Paolo
    Corsi, Massimiliano Marco
    INTERNATIONAL ORTHOPAEDICS, 2011, 35 (05) : 777 - 782
  • [8] Plasma and drainage fluid levels of soluble receptor activator of nuclear factor-kB (sRANK), soluble receptor activator of nuclear factor-kB ligand (sRANKL) and osteoprotegerin (OPG) during proximal humerus fracture healing
    Alessandra Colombini
    Giovanni Lombardi
    Emanuela Galliera
    Giada Dogliotti
    Pietro Randelli
    Alexander Meerssemann
    Giuseppe Mineo
    Paolo Cabitza
    Massimiliano Marco Corsi
    International Orthopaedics, 2011, 35 : 777 - 782
  • [9] Levels of osteoprotegerin (OPG) and receptor activator for nuclear factor kappa B ligand (RANKL) in serum: Are they of any help?
    Wagner, Doris
    Fahrleitner-Pammer, Astrid
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2010, 160 (17-18) : 452 - 457
  • [10] Serum levels of osteoprotegerin and receptor activator of nuclear factor kB ligand (RANKL) in children with various stages of chronic renal disease
    Siomou, E.
    Challa, A. S.
    Petropoulou, F.
    Siapera, D.
    Mitsioni, A.
    Stefanidis, C. J.
    BONE, 2007, 40 (06) : S33 - S33
12345